XML 42 R33.htm IDEA: XBRL DOCUMENT v3.24.1
Stock Incentive Plan (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity during the year ended December 31, 2023:

 

 

 

Number of Options

 

 

Weighted-Average
Exercise Price
(per Share)

 

 

Weighted-Average
Remaining
Contract Term
(in Years)

 

Aggregate Intrinsic Value
(in Thousands)

 

Outstanding at December 31, 2022

 

 

9,637,022

 

 

$

5.35

 

 

 

 

 

 

Exercisable at December 31, 2022

 

 

4,066,881

 

 

 

4.17

 

 

 

 

 

 

 

Granted

 

 

3,167,750

 

 

 

1.08

 

 

 

 

 

 

 

Exercised

 

 

(23,479

)

 

 

0.56

 

 

 

 

 

 

 

Canceled or forfeited

 

 

(1,029,544

)

 

 

5.56

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

11,751,749

 

 

$

4.19

 

 

 

8.0

 

$

93

 

Exercisable at December 31, 2023

 

 

6,045,163

 

 

$

4.55

 

 

 

7.3

 

$

52

 

Summary of Equity Based Compensation Expense

The classification of stock-based compensation expense is summarized as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

3,748

 

 

$

3,970

 

Selling, general and administrative

 

 

7,656

 

 

 

9,699

 

Total stock-based compensation expense

 

$

11,404

 

 

$

13,669

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table shows the weighted-average assumptions used to compute the fair value of the awards granted to employees and nonemployees using the Black-Scholes option pricing model during the periods below:

 

 

 

Year Ended December 31,

Assumption

 

2023

 

2022

Expected volatility

 

72.47%

 

57.56%

Expected term (years)

 

5.36.1

 

5.26.1

Expected dividend yield

 

0.00%

 

0.00%

Risk-free interest rate

 

4.15%

 

1.98%

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance under equity incentive plans consisted of the following as of December 31, 2023:

 

Stock options and restricted stock units issued and outstanding under all Plans

 

 

15,829,198

 

Authorized for future grants under the 2021 Plan

 

 

3,810,957

 

Authorized for future purchases under the ESPP

 

 

540,679

 

Total as of December 31, 2023

 

 

20,180,834

 

 

The table above does not include 34,384 of common stock for early exercised stock options that remain subject to the Company’s repurchase right.

Schedule of RSU activity during the year

Restricted stock units (“RSUs”) represent the right to receive common stock, subject to vesting for continued service to the Company. The following table summarizes RSU activity during the year ended December 31, 2023:

 

 

 

Number of Units

 

 

Weighted-Average
Grant Date
Fair Value
(per Unit)

 

 

Outstanding at December 31, 2022

 

 

-

 

 

$

-

 

 

 

Granted

 

 

4,743,850

 

 

 

1.13

 

 

 

Vested

 

 

(415,528

)

 

 

1.78

 

 

 

Canceled

 

 

(250,873

)

 

 

1.88

 

 

Outstanding at December 31, 2023

 

 

4,077,449

 

 

$

1.02